Confusion in the Elderly After Colon Surgery

June 15, 2012 updated by: Mitchell Chorost, New York Hospital Queens

Cognitive Changes After Surgery in the Elderly: Does Minimally Invasive Surgery Influence the Incidence of Postoperative Cognitive Changes Compared to Open Colon Surgery?

A study will be conducted to determine if there is any cognitive benefit in elderly patients having open versus minimally invasive colon cancer surgery.

Study Overview

Detailed Description

Cognitive changes in the elderly are common after surgery. It is not known if minimally invasive or laparoscopic surgery can prevent these changes. A study will be conducted on patients scheduled to have abdominal surgery. The patients will have cognitive evaluations before and after surgery. A small amount of blood, about 2 tablespoons, will be collected no more than 5 times in 6 months. The results will be analyzed to determine if there are changes between those having open surgery versus patients having laparoscopic or minimally invasive surgery, and if these changes coincide with cognitive changes.

Study Type

Observational

Enrollment (Anticipated)

52

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

  • Name: Mitchell I Chorost, MD
  • Phone Number: 718-670-1185
  • Email: mchorost@nyp.org

Study Locations

    • New York
      • Flushing, New York, United States, 11355
        • Recruiting
        • New York Hospital Queens
        • Contact:
        • Principal Investigator:
          • Mitchell I Chorost, MD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

65 years and older (Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

Patients newly diagnosed with colon adenocarcinoma will be contacted after being scheduled for surgery at New York Hospital Queens.

Description

Inclusion Criteria:

  • Patients over age 65.0 years and in need of elective colon resection for adenocarcinoma

Exclusion Criteria:

  • Inability to complete preoperative cognitive screening
  • Inability to complete study in English since CANTAB is timed and not validated with interpreters
  • Emergency surgery
  • Depression or psychiatric comorbidity
  • Pre-existing dementia
  • Previous cerebrovascular accident or "stroke"
  • Previous myocardial infarction
  • Cardiac ejection fraction below 55%
  • Propranolol, metoprolol or other betablocker use
  • Digoxin, procainamide, or amiodarone use
  • Calcium channel blocker use
  • History of vascular surgery or arterial vascular disease
  • History of alcohol dependence
  • Lovastatin or other HMG-CoA reductase inhibitor use
  • Ace inhibitor use
  • Neuroendocrine or catecholamine associated tumors
  • Hypertension
  • Diabetes
  • Benzodiazepine use
  • Dimenhydrinate or other medications to treat motion sickness
  • Metaclopramide use

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Laparoscopic colon surgery
Patients over age 65 having laparoscopic colon resection for colonic adenocarcinoma
Open colon surgery
Patients over age 65 having open colon resection for colonic adenocarcinoma

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Confusion
Time Frame: 6 Months
Confusion assessed by questionaires and cognitive testing
6 Months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
degree of inflammation
Time Frame: 6 Months
5 separate blood draws
6 Months
presence of electrolyte imbalance
Time Frame: 6 months
5 separate blood draws
6 months
pituitary-thyroid axis disruption
Time Frame: 6 months
5 separate blood draws
6 months
liver function tests
Time Frame: 6 months
5 separate blood draws
6 months
nutritional status
Time Frame: 6 months
5 separate blood draws
6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Mitchell I Chorost, MD, New York Hospital Queens

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

January 1, 2012

Primary Completion (Anticipated)

January 1, 2015

Study Completion (Anticipated)

January 1, 2015

Study Registration Dates

First Submitted

April 23, 2012

First Submitted That Met QC Criteria

June 15, 2012

First Posted (Estimate)

June 19, 2012

Study Record Updates

Last Update Posted (Estimate)

June 19, 2012

Last Update Submitted That Met QC Criteria

June 15, 2012

Last Verified

June 1, 2012

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Inflammation

3
Subscribe